Advanced search
Showing results 1221 to 1240 on 6522 in total
-
Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up.
Gérald Raverot, Anne Wierinckx, Emmanuelle Dantony, Carole Auger, Guillaume Chapas, Laurent Villeneuve, Thierry Brue, Dominique Figarella-Branger, Pascal Roy, Emmanuel Jouanneau, Michel Jan, Joël Lachuer, Jacqueline Trouillas, Non Renseigné
-
[Methodological tools for critical reading of scientific articles in medicine].
Pascal Roy, Delphine Maucort-Boulch
-
Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review
R. Le Scodan, F. Mornex, N. Girard, C. Mercier, P.-J. Valette, M. Ychou, F. Bibeau, Pascal Roy, J.-Y. Scoazec, C. Partensky
-
Analyse de survie
Pascal Roy, Ph. Broët, C. Quantin
-
Biostatistique
Régis Beuscart, Jacques Bénichou, Pascal Roy, Catherine Quantin
-
Mixed-model of ANOVA for measurement reproducibility in proteomics
C. Truntzer, D. Pecqueur, Jp. Gimeno, G. Belz, Pascal Roy, Catherine Mercier
-
Eléments méthodologiques pour la lecture critique d'article
Pascal Roy, Delphine Maucort-Boulch
-
Quels risques pour quelles femmes? Risque populationnel de cancer du sein
Pascal Roy
-
Inter-observer agreement in the identiWcation of the two bundles of the anterior cruciate ligament using magnetic resonance imaging
M. Montoy, T.Hierry Euvrard, B. Moyen, Pascal Roy, J.-C. Rollier, F. Cotton
-
Comparative optimism in models involving both classical clinical and gene expression information
C. Truntzer, Delphine Maucort-Boulch, Pascal Roy
-
Histopathological Response to Preoperative Chemoradiation for Resectable Pancreatic Adenocarcinoma: the French phase IIFFCD 9704-SFRO trial
R. Le Scodan, F. Mornex, C. Partensky, P-J. Valette, M. Ychou, Pascal Roy, J-Y. Scoazec, Catherine Mercier
-
Plasminogen Activator Inhibitor Type 1 is the Most Significant of the Usual Tissue Prognostic Factors in Node-Negative Breast Ductal Adenocarcinoma Independent of Urokinase-Type Plasminogen Activator
F. Descotes, B. Riche, S. Saez, G. de Laroche, J. Datchary, Pascal Roy, P. André, J.-Y. Bobin
-
Importance of data structure in comparing two dimension reduction methods for classification of microarray gene expression data
C. Truntzer, Catherine Mercier, Jaume Esteve, Christian Gautier, Pascal Roy
-
Rheumatoid arthritis and genetic markers in Syrian and French populations: different impact of the shared epitope
L. Kazkaz, H. Marotte, M. Hamwi, M.A. Cazalis, Pascal Roy, B. Mougin
-
Predictive and discriminating three-risk-group prognostic scoring system for staging Hodgkin lymphomas
Delphine Maucort-Boulch, M. Djeridane, Pascal Roy, B. Riche, P. Colonna, J.M. Andrieu
-
Seasonality of exposure of cattle to BSE in France
Carole Sala, Eric Morignat, Pascal Roy, Christian Ducrot, Didier Calavas
-
Feasibility of pre-operative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial
F. Mornex, Nicolas Girard, J.Y. Scoazec, Nadine Bossard, M. Ychou, D. Smith, J.F. Seitz, P.J. Valette, Pascal Roy, P. Rouanet, M. Ducreux, C. Partensky
-
Extensive multiallelic analysis of the relationship between HLA-DRB1 and rheumatoid arthritis using a Bayesian partition model
H. Marotte, M. Tournoud, M.A. Cazalis, B. Mougin, Pascal Roy, P. Miossec
-
Modeling the effect of tamoxifen chemoprevention on long-term mortality in white women at high risk of breast cancer
Delphine Maucort-Boulch, Pascal Roy
-
Preoperative Chemotherapy Does Not Increase Complications After Nonsmall Cell Lung Cancer Resection
Emilie Perrot, Benoit Guibert, Pierre Mulsant, Sonia Blandin, Isabelle Arnaud, Pascal Roy, Laurence Geriniere, Pierre-Jean Souquet